-
1
-
-
0001514088
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management: The AFFIRM Study design
-
The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management: The AFFIRM Study design. Am J Cardiol. 1997;79:1198-1202.
-
(1997)
Am J Cardiol
, vol.79
, pp. 1198-1202
-
-
-
2
-
-
0036082471
-
Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study
-
The AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002;143:991-1001.
-
(2002)
Am Heart J
, vol.143
, pp. 991-1001
-
-
-
3
-
-
0037028022
-
A comparison of rate control and rhythm control in patients with atrial fibrillation
-
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
-
(2002)
N Engl J Med
, vol.347
, pp. 1825-1833
-
-
-
4
-
-
0035902567
-
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy
-
Pederson OD, Bagger H, Keller N, et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy. Circulation. 2001;104:292-296.
-
(2001)
Circulation
, vol.104
, pp. 292-296
-
-
Pederson, O.D.1
Bagger, H.2
Keller, N.3
-
6
-
-
0026011647
-
Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial
-
Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.
-
(1991)
N Engl J Med
, vol.324
, pp. 781-788
-
-
Echt, D.S.1
Liebson, P.R.2
Mitchell, L.B.3
-
7
-
-
0026752875
-
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
-
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992;327:227-233.
-
(1992)
N Engl J Med
, vol.327
, pp. 227-233
-
-
-
8
-
-
0025735814
-
Events in the Cardiac Arrhythmia Suppression Trial (CAST): Mortality in the entire population enrolled
-
Epstein AE, Bigger JT, Wyse DG, et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. J Am Coll Cardiol. 1991;18:14-19.
-
(1991)
J Am Coll Cardiol
, vol.18
, pp. 14-19
-
-
Epstein, A.E.1
Bigger, J.T.2
Wyse, D.G.3
-
9
-
-
8944234858
-
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
-
Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7-12.
-
(1996)
Lancet
, vol.348
, pp. 7-12
-
-
Waldo, A.L.1
Camm, A.J.2
DeRuyter, H.3
-
10
-
-
0026649118
-
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
-
Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol. 1992;20:527-532.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 527-532
-
-
Flaker, G.C.1
Blackshear, J.L.2
McBride, R.3
-
11
-
-
11144358231
-
Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study
-
In press
-
Steinberg JS, Sadaniantz A, Kron J, et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation. In press.
-
Circulation
-
-
Steinberg, J.S.1
Sadaniantz, A.2
Kron, J.3
-
12
-
-
0038300657
-
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation
-
Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J Am Coll Cardiol. 2003;42:185-197.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 185-197
-
-
Pappone, C.1
Rosanio, S.2
Augello, G.3
-
13
-
-
0028244264
-
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation
-
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med. 1994;154:1449-1457.
-
(1994)
Arch Intern Med
, vol.154
, pp. 1449-1457
-
-
-
14
-
-
0037179656
-
Warfarin, aspirin or both after myocardial infarction
-
Hurlen M, Abdelnoor M, Smith P, et al. Warfarin, aspirin or both after myocardial infarction. N Engl J Med. 2002;347:969-974.
-
(2002)
N Engl J Med
, vol.347
, pp. 969-974
-
-
Hurlen, M.1
Abdelnoor, M.2
Smith, P.3
-
15
-
-
0037453950
-
Association of serum digoxin concentration and outcomes in patients with heart failure
-
Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289:871-878.
-
(2003)
JAMA
, vol.289
, pp. 871-878
-
-
Rathore, S.S.1
Curtis, J.P.2
Wang, Y.3
|